Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
1. A method of treating a middle or inner ear disorder comprising intratympanically administering to an individual in need thereof a controlled release composition comprising a pharmaceutical agent and a thermosetting polymer; wherein the pharmaceutical agent is selected from an uncoated antibacterial agent and is suspended in the composition, and the thermosetting polymer has a gelation temperature of between about 12° C. to about 20° C., wherein the middle or inner ear disorder is a viral or bacterial infection,
wherein the thermosetting polymer is poloxamer 407 and has a concentration of about 20% (w/w), and
wherein the antibacterial agent is fluoroquinolone.
2. The method of claim 1 , wherein the controlled release composition provides controlled release of the pharmaceutical agent for an extended period of time of one or more days.
3. The method of claim 1 , wherein the controlled release composition further comprises a phosphate which buffers the pH of the controlled release composition to a pH range of about 7.0-7.6.
4. The method of claim 1 , wherein the controlled release composition is contained in a syringe.
5. The method of claim 4 , wherein a single dose of the controlled release composition in the syringe is at least 50 μL.
6. The method of claim 1 , wherein the controlled release composition is administered by injecting it into the middle ear.
7. The method of claim 1 , wherein the controlled release composition is administered by injection or surgical manipulation.